Massachusetts’ Entasis Snags $31.9 Million To Advance Anti-infective Therapeutic Portfolio

“We welcome this strong support from a group of experienced and successful investors who understand the need and market opportunity for new medicines to combat multi drug-resistant bacterial infections”

• Source: biospace
• 493
• November 23, 2017